Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart ultrasound may guide better septic shock treatment

NCT ID NCT07438301

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study will use echocardiograms (heart ultrasounds) to see how the heart responds to two common treatments for septic shock: intravenous fluids and vasopressors (medicines that raise blood pressure). Researchers will measure changes in heart function before and 15 minutes after treatment in 180 adults with septic shock. The goal is to understand which approach improves blood flow better, which could help doctors make more informed resuscitation decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Siriraj Hospital

    Bangkok, 10700, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors choose the best resuscitation method for septic shock patients based on heart function changes.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients, and the small size (180 participants) limits generalizability.

Conditions

The condition(s) this trial relates to.

Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.